548 Results for "

Piper lenticellosum C.DC.

" in MedChemExpress (MCE) Product Catalog:
Products (548)

548 Results for "Piper lenticellosum C.DC." in MCE Product Catalog:

311
311 Publications Verification
Art. -Nr.: HY-10182
CAS. Nr.: 252917-06-9
Reinheit:  99.43%
Synonyms: CHIR-99021; CT99021
Forschungsgebiete:  

Metabolic Disease Cancer

Laduviglusib (CHIR-99021) is a potent, selective and orally active GSK-3α/β inhibitor with IC50s of 10 nM and 6.7 nM. Laduviglusib shows >500-fold selectivity for GSK-3 over CDC2, ERK2 and other protein kinases. Laduviglusib is also a potent Wnt/β-catenin signaling pathway activator. Laduviglusib enhances mouse and human embryonic stem cells self-renewal. Laduviglusib induces autophagy .
loading...
    loading...
311
311 Publications Verification
Art. -Nr.: HY-10182B
CAS. Nr.: 1782235-14-6
Reinheit:  99.07%
Synonyms: CHIR-99021 trihydrochloride; CT99021 trihydrochloride
Forschungsgebiete:  

Cancer

Laduviglusib (CHIR-99021) trihydrochloride is a potent and selective GSK-3α/β inhibitor with IC50s of 10 nM and 6.7 nM. Laduviglusib trihydrochloride shows >500-fold selectivity for GSK-3 over CDC2, ERK2 and other protein kinases. Laduviglusib trihydrochloride is also a potent Wnt/β-catenin signaling pathway activator. Laduviglusib trihydrochloride enhances mouse and human embryonic stem cells self-renewal. Laduviglusib trihydrochloride induces autophagy .
loading...
    loading...
311
311 Publications Verification
Art. -Nr.: HY-10182A
CAS. Nr.: 1797989-42-4
Reinheit:  99.93%
Synonyms: CHIR-99021 monohydrochloride; CT99021 monohydrochloride
Forschungsgebiete:  

Cancer

Laduviglusib (CHIR-99021) monohydrochloride is a potent and selective GSK-3α/β inhibitor with IC50s of 10 nM and 6.7 nM. Laduviglusib monohydrochloride shows >500-fold selectivity for GSK-3 over CDC2, ERK2 and other protein kinases. Laduviglusib monohydrochloride is also a potent Wnt/β-catenin signaling pathway activator. Laduviglusib monohydrochloride enhances mouse and human embryonic stem cells self-renewal. Laduviglusib monohydrochloride induces autophagy .
loading...
    loading...
39
39 Cited Publications
Art. -Nr.: HY-12646
CAS. Nr.: 1281870-42-5
Reinheit:  99.93%
Target:  

Ras Apoptosis

Forschungsgebiete:  

Cancer

Rhosin hydrochloride is a potent, specific RhoA subfamily Rho GTPases inhibitor. Rhosin hydrochloride specifically binds to RhoA to inhibit RhoA-GEF interaction with a Kd of ~ 0.4 uM, and does not interact with Cdc42 or Rac1, nor the GEF, LARG. Rhosin hydrochloride induces cell apoptosis . Rhosin hydrochloride promotes stress resiliency through enhancing D1-MSN plasticity and reducing hyperexcitability .
loading...
    loading...
39
39 Cited Publications
Art. -Nr.: HY-12646A
CAS. Nr.: 1173671-63-0
Reinheit:  95.08%
Target:  

Ras Apoptosis

Forschungsgebiete:  

Cancer

Rhosin is a potent, specific RhoA subfamily Rho GTPases inhibitor, which specifically binds to RhoA to inhibit RhoA-GEF interaction with a Kd of ~ 0.4 uM, and does not interact with Cdc42 or Rac1, nor the GEF, LARG. Rhosin induces cell apoptosis . Rhosin promotes stress resiliency through enhancing D1-MSN plasticity and reducing hyperexcitability .
loading...
    loading...
35
35 Cited Publications
Art. -Nr.: HY-30237
CAS. Nr.: 186692-46-6
Synonyms: Seliciclib; CYC202
Target:  

CDK

(R)-Roscovitine (Seliciclib) is an orally bioavailable, selective and BBB-permeable CDKs inhibitor with IC50s of 0.2 μM, 0.65 μM, and 0.7 μM for CDK5, Cdc2, and CDK2, respectively.
loading...
    loading...
34
34 Cited Publications
Art. -Nr.: HY-12755
CAS. Nr.: 71203-35-5
Reinheit:  99.96%
Synonyms: CID-2950007
Target:  

Ras Apoptosis

Forschungsgebiete:  

Cancer

ML141 (CID-2950007) is a potent, allosteric, selective and reversible non-competitive inhibitor of Cdc42 GTPase. ML141 inhibits Cdc42 wild type and Cdc42 Q61L mutant with EC50s of 2.1 and 2.6 μM, respectively. ML141 shows low micromolar potency and selectivity against other members of the Rho family of GTPases (Rac1, Rab2, Rab7). ML141 do not show cytotoxicity in multiple cell lines .
loading...
    loading...
15
15 Cited Publications
Art. -Nr.: HY-15154
CAS. Nr.: 212779-48-1
Reinheit:  99.88%
Synonyms: Compound 52
Target:  

CDK

Forschungsgebiete:  

Cancer

NG 52 is a potent, cell-permeable, selective, ATP-compatible and orally active Cdc28p and Pho85p kinase inhibitor with IC50s of 7 μM and 2 μM, respectively. NG 52 also inhibits the activity of phosphoglycerate kinase 1 (PGK1) with an IC50 of 2.5 μM. NG 52 is inactive against yeast kinases Kin28p, Srb10, and Cak1p .
loading...
    loading...
13
13 Cited Publications
Art. -Nr.: HY-100888
CAS. Nr.: 1330782-76-7
Reinheit:  99.94%
Synonyms: TAK-931
Target:  

CDK

Forschungsgebiete:  

Cancer

Simurosertib (TAK-931) is an orally active, selective and ATP-competitive cell division cycle 7 (CDC7) kinase inhibitor, with an IC50 of <0.3 nM. Simurosertib has anti-cancer activity .
loading...
    loading...
12
12 Cited Publications
Art. -Nr.: HY-112842
CAS. Nr.: 2097938-73-1
Reinheit:  99.64%
Target:  

Ras CDK

Forschungsgebiete:  

Cancer

MBQ-167 is a dual Rac/Cdc42 inhibitor, with IC50s of 103 nM for Rac 1/2/3 and 78 nM for Cdc42 in MDA-MB-231 cells, respectively.
loading...
    loading...
10
10 Cited Publications
Art. -Nr.: HY-12874
CAS. Nr.: 425399-05-9
Reinheit:  99.89%
Target:  

Ras Apoptosis

Forschungsgebiete:  

Cancer

CASIN is a selective GTPase Cdc42 inhibitor with an IC50 of 2 uM. CASIN can be used for the research of cancer .
loading...
    loading...
10
10 Cited Publications
Art. -Nr.: HY-13076
CAS. Nr.: 252935-94-7
Reinheit:  98.44%
Target:  

GSK-3

Forschungsgebiete:  

Metabolic Disease

CHIR-98014 is a potent, cell-permeable GSK-3 inhibitor with IC50s of 0.65 and 0.58 nM for GSK-3α and GSK-3β, respectively; it shows less potent activities against cdc2 and erk2.
loading...
    loading...
9
9 Cited Publications
Art. -Nr.: HY-108543
CAS. Nr.: 93718-83-3
Reinheit:  ≥99.0%
Target:  

Phosphatase Apoptosis

Forschungsgebiete:  

Cancer

NSC 95397 is a potent, selective Cdc25 dual specificity phosphatase inhibitor (Ki=32 nM (Cdc25A), 96 nM (Cdc25B), 40 nM (Cdc25C); IC50=22.3 nM (human Cdc25A), 56.9 nM (human Cdc25C), 125 nM (Cdc25B)) . NSC 95397 inhibits mitogen-activated protein kinase phosphatase-1 (MKP-1) and suppresses proliferation and induces apoptosis in colon cancer cells through MKP-1 and ERK1/2 pathway .
loading...
    loading...
9
9 Cited Publications
Art. -Nr.: HY-110287
CAS. Nr.: 300815-04-7
Reinheit:  99.62%
Target:  

APC Mitosis

Forschungsgebiete:  

Cancer

Apcin, a ligand of Cdc20, is a potent and competitive anaphase-promoting complex/cyclosome (APC/C(Cdc20)) E3 ligase activity inhibitor. Apcin competitively inhibits APC/C-dependent ubiquitylation by binding to Cdc20 and preventing substrate recognition. Apcin occupes the D-box-binding pocket on the side face of the WD40-domain and can prolong mitosis .
loading...
    loading...
9
9 Cited Publications
Art. -Nr.: HY-15339
CAS. Nr.: 199986-75-9
Reinheit:  99.90%
Synonyms: Cdk2 Inhibitor III
Target:  

CDK

Forschungsgebiete:  

Cancer

CVT-313 (Cdk2 Inhibitor III) is a potent, selective, reversible, and ATP-competitive inhibitor of CDK2 with IC50 of 0.5 μM. CVT-313 inhibits CDC5L phosphorylation .
loading...
    loading...
8
8 Cited Publications
Art. -Nr.: HY-B0294
CAS. Nr.: 31430-15-6
Flubendazole is an anthelmintic drug based on altering microtubule structure, inhibition of tubulin polymerization and disruption of microtubule function. Flubendazole induces apoptosis in human colorectal cancer (CRC) by blocking the STAT3 signaling axis and activation of autophagy. Flubendazole induces P53 expression and reduced Cyclin B1 and p-cdc2 expression. Flubendazole is an antitumor agent. Flubendazole can be used for worm and intestinal parasites .
loading...
    loading...
7
7 Cited Publications
Art. -Nr.: HY-15260
CAS. Nr.: 1169558-38-6
Reinheit:  99.76%
Synonyms: BMS-863233
Target:  

CDK

Forschungsgebiete:  

Cancer

XL413 is a potent, selective and ATP competitive inhibitor of Cdc7, with an IC50 of 3.4 nM, and also shows potent effect with IC50s of 215, 42 nM on CK2, PIM1, respectively, and an EC50 of 118 nM on pMCM.
loading...
    loading...
7
7 Cited Publications
Art. -Nr.: HY-15260A
CAS. Nr.: 2062200-97-7
Reinheit:  99.65%
Synonyms: BMS-863233 monohydrochloride
Target:  

CDK

Forschungsgebiete:  

Cancer

XL413 (BMS-863233) hydrochloride is a potent, selective and ATP competitive inhibitor of Cdc7, with an IC50 of 3.4 nM, and also shows potent effect with IC50s of 215, 42 nM on CK2, PIM1, respectively, and an EC50 of 118 nM on pMCM.
loading...
    loading...
6
6 Cited Publications
Art. -Nr.: HY-100034
CAS. Nr.: 383907-43-5
Reinheit:  99.29%
Synonyms: DA-3003-1
Forschungsgebiete:  

Cancer

NSC 663284 (DA-3003-1) is a potent, cell-permeable, and irreversible Cdc25 dual specificity phosphatase inhibitor, has an IC50 for Cdc25B2 of 0.21 μM. NSC 663284 exhibits mixed competitive kinetics against Cdc25A, Cdc25B(2), and Cdc25C with Ki values of 29, 95, and 89 nM, respectively . NSC 663284 inhibits NSD2 (IC50 of 170 nM) through a direct interaction with the catalytic SET domain (Kd of 370 nM) .
loading...
    loading...
6
6 Cited Publications
Art. -Nr.: HY-N0417
CAS. Nr.: 18444-66-1
Synonyms: α-Elaterin; α-Elaterine
Cucurbitacin E is a CDK1 inhibitor that significantly inhibits the activity of the cyclin B1/CDC2 complex. Cucurbitacin E also induces PANoptosis in adrenocortical carcinoma cells in a ZBP1-dependent manner. Cucurbitacin E exhibits synergistic effects with Mitotane (HY-13690); when used in combination, they effectively eliminate tumors .
loading...
    loading...